Tronox Titanium Volumes Surge, but 11.4x Leverage Clouds Recovery

Tronox’s TiO2 volumes rose 18% in Q2 2026 and zircon volumes jumped 61%. The same quarter still produced a $171 million GAAP net loss, and the company is carrying leverage of roughly 11.4x. For investors weighing Tronox Holdings and its titanium value chain, that gap between volume and profit is the signal most “recovery” headlines skip.

Tronox Holdings (NYSE: TROX) is the world’s largest vertically integrated producer of titanium dioxide (TiO2), the white pigment used in paint, plastics and paper. Vertical integration means the company owns the whole chain, from the mineral sands mines in Western Australia and South Africa through to the pigment plants.

That structure is the core of the investment debate. Owning the mines can protect costs when prices fall. It can also tie up capital and add operating risk at a point in the cycle when the balance sheet has little room for error.

This piece sets out how to judge whether the recovery is real, how Tronox compares with non-integrated rival Chemours, and which risks could break the thesis.

What does vertical integration actually give Tronox in the titanium value chain?

At its simplest, Tronox puts ore and pigment on one balance sheet. The chain runs in five steps:

1. Mine titanium-bearing mineral sands.
2. Separate the minerals: ilmenite, rutile, leucoxene (titanium-bearing minerals of varying purity) and zircon.
3. Process the titanium minerals into feedstock, the raw input for pigment plants.
4. Convert feedstock into TiO2 pigment at plants in 10 countries across the Americas, Europe and Australia.
5. Sell pigment to coatings, plastics and paper customers, and sell zircon separately.

Each step a company owns is a step where it keeps the margin, and a step where it carries the cost. When feedstock prices spike, Tronox sources its input close to mining cash cost and with secure supply, which places it lower on the industry cost curve (the ranking of producers from cheapest to most expensive). When demand falls, the mines still carry fixed costs and still need capital.

Each step in the chain from ore to pigment sits within a wider titanium industry processing framework, where feedstock grades, smelting capacity and pigment demand interact; that interaction explains why integrated producers can behave so differently from non-integrated peers.

That trade shapes how the stock behaves. Tronox reads less like a pure chemicals company and more like a mining business with a chemicals division attached.

Where the mines sit

Western Australia hosts the Cooljarloo and Chandala operations. South Africa hosts two chains: Namakwa Sands, and Hillendale with KZN Sands, both held through wholly owned subsidiaries.

South Africa accounts for a major portion of reserves. A May 2025 investor presentation put Namakwa Sands’ 2024 output at 521,000 tonnes of ilmenite, 27,000 tonnes of rutile and leucoxene and 83,000 tonnes of zircon, figures not independently confirmed. In 2025 Tronox commissioned the Fairbreeze extension and completed construction at Namakwa East, and Namakwa Sands carried a net book value of $552 million at 31 December 2025.

For you as an investor, this means TROX returns depend on mine economics and South African and Australian operating conditions as much as on the pigment price.

What do Tronox’s latest results say about the recovery?

The top line looked like a turnaround. Q2 2026 revenue reached $868 million, up 19% year-on-year, reported in early August.

TiO2 revenue came in at $700 million on volumes up 18%. Zircon revenue rose to $97 million on a 61% volume surge.

Look at the price column. TiO2 pricing was flat on the year, though up about 5% sequentially, and zircon prices fell 18% even as volumes soared. More product is moving, but it is not yet selling for much more.

Then come the earnings. Adjusted EBITDA (earnings before interest, tax, depreciation and amortisation, stripped of one-off items) was only $73 million. The adjusted net loss was $82 million, and the GAAP loss of $171 million included a $103 million tax valuation allowance. Free cash flow of $60 million was the brightest line on the profit side.

The split screen $868 million in revenue, a $171 million GAAP net loss.

The backdrop explains the weakness. FY 2025 net sales fell 6% to $2,898 million, and gross margin collapsed to 9.3% from 16.8% in 2024. The 10-K shows TiO2 at roughly 79-80% of sales, zircon about 9-10% and other products about 11%, so pigment remains the earnings engine.

Volumes recovering faster than margins tells you the cycle has turned, but the earnings leverage the bulls want has not yet arrived.

Tronox versus Chemours: does owning the mine help or hurt?

Chemours offers the cleanest contrast. It makes TiO2 but owns no mines, buying feedstock under contracts and on the open market.

The pricing evidence favours the bulls for now. Chemours’ 19 February 2026 release showed lower TiO2 pricing and volumes, but it then pushed through global increases effective 1 April 2026 and 1 June 2026. That delivered about 3% sequential price gains in Q1 and about 5% year-to-date, broadly matching Tronox’s own 5% sequential TiO2 gain.

The comparison has limits. Chemours’ full TiO2 segment revenue, EBITDA and volumes were not available, so this is a structural comparison rather than a full financial one.

And here is the uncomfortable part. Both companies sell into the same demand curve, and Chinese sulfate-route producers have expanded capacity enough to cap how far either can push prices on commodity grades.

If you hold or are considering either stock, the question is whether you would rather be exposed to mine and jurisdiction risk with Tronox, or to feedstock price swings with Chemours.

Is the TiO2 destocking cycle really over, and what would it take to confirm it?

The bull case rests on two pillars. The first is the end of destocking: coatings, plastics and paper customers cut inventories hard through 2023-2024, starving producers of orders. The second is a return to more normal construction activity in China.

The Q2 numbers fit that story well. Volumes of 18% and 61%, plus positive sequential pricing across both products, look like customers restocking rather than a one-off. Company commentary updated on 24 September 2026, not independently confirmed, points to Q4 TiO2 volumes rising 3-5% and zircon 15-20% sequentially, net of a roughly 2% headwind from idling the Fuzhou plant in China.

The earnings test Q3 2026 adjusted EBITDA guidance: $95-115 million, against $73 million in Q2.

That is where the disagreements begin. Named analyst and rating-agency views after 2024 were not found, so the debate here draws on company and peer evidence.

Timing is the first fault line: rapid normalisation, or years of modest growth if Chinese construction stays soft. Pricing power is the second, since sceptics see the Chemours and Tronox increases as fragile against Chinese overcapacity. Zircon is the third, with strong volumes pointing to early-cycle ceramics and foundry demand while prices remain 18% lower than a year ago.

The TZMI Mineral Sands Report tracks titanium feedstock, zircon and TiO2 pigment supply, demand and pricing, which is the industry data set needed to test whether Chinese capacity and export pricing will cap the recovery in sequential TiO2 prices.

Three signals will settle the argument:

• Sequential TiO2 price: whether quarter-on-quarter gains continue beyond the Chemours increases.
• Zircon price trajectory: whether the guided mid- to high-single-digit Q3 rise holds.
• Chinese construction data: the demand driver behind both pigment and export pricing.

Sequential volume and price gains are what you should track, because year-on-year comparisons still flatter or mask the real direction.

Balance sheet, South Africa and cyclicality: the risks that could break the thesis

Ranked from most to least quantifiable, the risks stack up as follows:

1. Leverage: net debt of about $3.036 billion against trailing-twelve-month adjusted EBITDA of $266 million, or roughly 11.4x at 30 June 2026.
2. South African operations: permitting, empowerment rules and power supply.
3. Cyclicality: TiO2 runs multi-year boom-bust cycles tied to construction.
4. Chinese competition: overcapacity and aggressive export pricing.
5. ESG and jurisdiction: scrutiny of mining in South Africa and Western Australia.

Leverage leads because the numbers are stark. Part of the debt dates to the 2019 Cristal acquisition, and Tronox added a $400 million senior secured bond in 2025. The dividend was cut 60% to $0.05 per share, and the $300 million buyback authorisation through February 2027 saw no repurchases in 2025.

Management also idled selected pigment and smelter capacity in 2025, including Fuzhou, to protect cash. Those are the moves of a company defending its balance sheet, not one positioned to reward shareholders yet.

South Africa: the risk behind the integration advantage

South Africa holds much of Tronox’s reserve base, so the case for integration leans heavily on it. Mining code and empowerment requirements shape permitting, and load-shedding and grid instability threaten steady output.

Rio Tinto’s South African mineral sands restart shows how another major producer is weighing the same permitting, power and cost pressures, and it sets a useful benchmark for judging Tronox’s own operating risk in the country.

Disruption there strikes directly at the feedstock cost advantage that justifies owning mines at all. A pigment-only rival can simply buy elsewhere; Tronox carries the fixed costs either way.

Further out, ESG scrutiny around rehabilitation, environmental impact and social licence may raise costs and cap valuation multiples. Past TiO2 downturns hit hardest the producers that had added leverage near the top.

At 11.4x leverage, a modest setback in pigment prices hits equity holders far harder than operating results alone would suggest, and you should size any position accordingly.

Past performance does not guarantee future results. Forward-looking statements and guidance are subject to market conditions and company performance.

Weighing Tronox as a titanium value chain investment

On one side sit genuine early-cycle signs: rebounding volumes, sequential price gains and integrated assets that should widen margins if the upturn holds. On the other sit 11.4x leverage, concentrated South African exposure, Chinese overcapacity and a cycle with a history of punishing indebted producers.

The Chemours comparison clarifies the choice. TROX gives you more operating leverage to a pigment recovery, paid for with mining and jurisdiction risk rather than feedstock price risk.

Tronox’s rare earth diversification push, backed by government support, adds an optionality angle to the thesis, though it does little to ease near-term leverage while pigment earnings rebuild.

Three variables will decide whether the thesis holds:

• Sequential pricing in TiO2 and zircon
• Deleveraging progress as EBITDA rebuilds
• South African operating stability across permitting and power

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions.